Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: A Randomized Double-Blind Controlled Trial

Abstract

Objectives:

To evaluate the impact of metformin on in vitro fertilization (IVF) outcomes in overweight and obese women with polycystic ovary syndrome (PCOS).

Methods:

This was a randomized double-blind placebo-controlled study (ClinicalTrials.gov: NCT 02910817) carried out in a University IVF Center. The study included 102 overweight and obese women (body mass index [BMI] >24 kg/m²) with PCOS who underwent their first fresh autologous IVF-embryo transfer cycle and agreed to participate in the study. The study participants were randomized into 2 groups: metformin group received metformin (1000 mg per day) at the start of controlled ovarian stimulation (COH) until the day of the pregnancy check, and placebo group received placebo tablets in the same duration. The primary outcome measure was the total number of retrieved oocytes.

Results:

Both groups were homogenous in baseline demographic characteristics. Metformin group versus the placebo group demonstrated decrease in the mean number of the retrieved oocytes (9.06 ± 4.23 vs 16.86 ± 8.3, P < .01) and similar live birth rate (LBR; 25.5% vs 17.6%, P = .34). The number of fertilized oocytes was lower in the metformin group (5.65 ± 2.66 vs 9 ± 4.55, P < .01). However, the fertilization rate was similar in both groups (62.3% vs 53.4%, P = .10). There was no difference in the implantation rate (15.7% vs 11.8%, P = .32), multiple pregnancy rate (13.4% vs 3.9%, P = .08), or miscarriage rate (23.5% vs 35.7%, P = .46). No cases of ovarian hyperstimulation syndrome (OHSS) were observed in both groups.

Conclusion:

Short-term administration of metformin to overweight or obese women with PCOS undergoing IVF decreased number of the retrieved oocytes but did not improve the LBR.

Synopsis

Metformin use could decrease the number of retrieved oocytes in overweight and obese women with polycystic ovary syndrome undergoing IVF.

Keywords

metformin polycystic ovary syndrome obesity overweight in vitro fertilization

Get full access to this article

View all access options for this article.

References

Dunaif

. Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus. Am J Med. 1995;98(1A):33S–39S.

Franks

. Polycystic ovary syndrome. New Eng J Med. 1995;333(13):853–861.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod. 2004;19(1):41–47.

Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89(3):505–522.

Gorry

White

Franks

. Infertility in polycystic ovary syndrome. Endocrine. 2006;30(1):27–33.

Sam

. Obesity and polycystic ovary syndrome. Obes Manag. 2007;3(2):69–73.

Venkatesan

Dunaif

Corbould

. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res. 2001;56:295–308.

Lashen

. Role of metformin in the management of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2010;1(3):117–128.

Dunaif

. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.

10.

Murakawa

Hasegawa

Kurabayashi

et al. Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med. 1999;44(1):23–27.

11.

Diamanti-Kandarakis

Kouli

Tsianateli

et al. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol. 1998;138(3):269–274.

12.

Nestler

Stovall

Akhter

Iuorno

Jakubowicz

. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril. 2002;77(2):209–215.

13.

Saenz

Fernandez-Esteban

Mataix

Ausejo

Roque

Moher

. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(3):CD002966.

14.

DeFronzo

Barzilai

Simonson

. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metabo. 1991;73(6):1294–1301.

15.

Moll

van der Veen

van Wely

. The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2007;13(6):527–537.

16.

Stadtmauer

Toma

Riehl

Talbert

. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertil Steril. 2001;75(3):505–509.

17.

Christianson

Zhao

Yemini

Leong

Shoham

. Metformin use in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey. J Assist Reprod Genet. 2015;32(3):401–406.

18.

Refuerzo

Viteri

Hutchinson

et al. The effects of metformin on weight loss in women with gestational diabetes: a pilot randomized, placebo-controlled trial. Am J Obstet Gynecol. 2015;212(3):389.e1–389.e9.

19.

Norman

Dewailly

Legro

Hickey

. Polycystic ovary syndrome. Lancet. 2007;370(9588):685–697.

20.

De Leo

la Marca

Ditto

Morgante

Cianci

. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril. 1999;72(2):282–285.

21.

Palomba

Falbo

Carrillo

et al. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Fertil Steril. 2011;96(6):1384–1390.e4.

22.

Palomba

Falbo

Di Cello

Cappiello

Tolino

Zullo

. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. Fertil Steril. 2011;96(5):1128–1133.

23.

Cooper

Noonan

Von Eckardstein

et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16(3):231–245.

24.

Gambineri

Pelusi

Vicennati

Pagotto

Pasquali

. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002;26(7):883–896.

25.

Costello

Chapman

Conway

. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod. 2006;21(6):1387–1399.

26.

Conway

Dewailly

Diamanti-Kandarakis

et al. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group’s Questionnaire. Eur J Endocrinol. 2014;171(4):489–498.

27.

De Leo

Musacchio

Morgante

Piomboni

Petraglia

. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod. 2006;21(9):2252–2256.

28.

Kjotrod

von During

Carlsen

. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Hum Reprod. 2004;19(6):1315–1322.

29.

Tso

Costello

Albuquerque

et al. Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a Cochrane review. Fertil Steril. 2015;104(3):542–544.

30.

Tang

Glanville

Orsi

Barth

Balen

. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006;21(6):1416–1425.

31.

Kumbak

Kahraman

. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization. Acta Obstet Gynecol Scand. 2009;88(5):563–568.

32.

Palomba

Falbo

La Sala

. Effects of metformin in women with polycystic ovary syndrome treated with gonadotrophins for in vitro fertilisation and intracytoplasmic sperm injection cycles: a systematic review and meta-analysis of randomised controlled trials. BJOG. 2013;120(3):267–276.